FL-VIRGIN-VOYAGES
Virgin Voyages, the new lifestyle brand set to disrupt the travel industry, today announced its exclusive on-demand champagne delivery service, Shake for Champagne™ . Continuing to create the most irresistible experiences at sea, Virgin Voyages is enabling Sailors to request champagne, anywhere on board Scarlet Lady, with a simple shake of their phone.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191009005133/en/
Those looking to take indulgence to the next level can also treat themselves in the newly revealed luxurious champagne lounge and caviar bar, Sip .
“It is never too early for champagne and there is always something to toast to while aboard Scarlet Lady. We want our Sailors to enjoy a glamorous holiday and what better way to feel like a RockStar than a sip of bubbly whenever and wherever you want it,” said Tom Mcalpin, president and CEO of Virgin Voyages.
SHAKE FOR CHAMPAGNE™
Virgin Voyages is giving its Sailors one more reason to celebrate all of life’s moments with its on-demand delivery service, Shake for Champagne™. When the Virgin Voyages Sailor App is shaken, a secret Virgin Voyages Champagne button is revealed and, with just one press, a bottle of Möet & Chandon Impérial will be delivered to the Sailor.
“There’s nothing more luxurious than having champagne at your beck and call or even a shake. We are committed to creating the world’s most irresistible travel brand, so we thought long and hard about how to help our Sailors effortlessly get a sip of bubbly during their voyage, and presto Shake for Champagne™ was conjured up!” said Nathan Rosenberg, CMO for Virgin Voyages.
Delivered in an eye-catching, gleaming Virgin red champagne bucket, which is sure to make everyone around envious, the service includes a 750ml bottle of Möet & Chandon Impérial with two glasses. Möet & Chandon Impérial is a blend of over 200 crus, mingling the full body of pinot noir with the suppleness of Meunier and the finesse of chardonnay – the perfect pairing for a day or evening sailing in the warm Caribbean sea.
SIP
Sip is a decadent lounge designed to be enjoyed with a chilled glass of bubbles. Featuring a diverse curation of champagne labels, including Moët & Chandon – Virgin Voyages’ featured champagne house. Sailors can opt for a glass of bubbles priced from $9 or splash out on a $1,000 vintage bottle. In a nod to Virgin’s quintessential British heritage and eccentricity, Sip will offer a signature afternoon high tea, which will delight the eyes as well as the taste buds, while celebrating oceanic elements.
Designed by the Virgin Voyages design team, with spatial design by HKS Hospitality Interiors, the lounge was inspired by the glamour and effervescence of champagne. Featuring a long marble bar with rose-gold inlay, Sip encourages Sailors to indulge in one of the most luxurious pairings of them all, champagne and caviar. Gold and rose-pink hues echo the color of the champagnes that will be served, and are beautifully offset by deep watery blues and carrara white marble bars and tables. The deep ocean blue banquette wall and carpet that wraps through the space, will create a chance to revel or relax at all times of day as the ship sails through the ocean’s blue waves.
LIMITED-TIME BOOKING OFFER
Sailors can toast to Virgin Voyages’ inaugural season now through November 30, as those who book April or May sailings will receive a complimentary special Virgin Voyages limited-edition bottle of Möet & Chandon Impérial in their cabin upon their arrival. In addition, Sailors who book now can snag their voyage with half off their deposit. Future Sailors and First Mates are invited to check out Virgin Voyages by visiting www.virginvoyages.com .
ABOUT VIRGIN VOYAGES
Virgin Voyages is a global lifestyle brand committed to creating the world’s most irresistible holiday. With operations in the US, UK, and Europe, Virgin Voyages currently has four ships on order with master shipbuilder Fincantieri.
With its inaugural season scheduled for 2020, Virgin Voyages’ first ship Scarlet Lady was designed to reflect a yacht’s sleek luxury. Featuring spaces designed by some of the top names in contemporary design, Scarlet Lady will be Adult-by-Design, a sanctuary at sea for the 18+ traveler.
A dose of ‘Vitamin Sea’ will be naturally intertwined across the entire ship, with well-being activated through a mix of high-energy moments coupled with relaxation and rejuvenation. The Scarlet Lady will also feature alluring entertainment and 20+ world-class intimate eateries on board. Putting a twist on luxury, which the company refers to as Rebellious Luxe, Virgin Voyages will offer incredible value for its Sailors with all restaurants, group fitness classes, soft drinks, gratuities, WiFi and many more Virgin surprises included within the voyage fare.
Scarlet Lady will sail from Miami to the Caribbean in 2020, hosting more than 2,770 sailors and 1,150 amazing crew from around the world. Keep watch on virginvoyages.com for more updates.
Follow Virgin Voyages:
Instagram: @virginvoyages
Facebook: @virginvoyages
Twitter: @virginvoyages
LinkedIn: Virgin Voyages
YouTube: Virgin Voyages
View source version on businesswire.com: https://www.businesswire.com/news/home/20191009005133/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom